London · Delayed Price · Currency is GBP · Price in EUR Theseus Pharmaceuticals Statistics
Total Valuation
LON:0H4A has a market cap or net worth of GBP 7.62 billion. The enterprise value is 12.40 billion.
| Market Cap | 7.62B |
| Enterprise Value | 12.40B |
Important Dates
The last earnings date was Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | May 7, 2025 |
Share Statistics
| Current Share Class | 1.20B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.02B |
Valuation Ratios
The trailing PE ratio is 5.02 and the forward PE ratio is 6.19.
| PE Ratio | 5.02 |
| Forward PE | 6.19 |
| PS Ratio | 0.22 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 8.17 |
| EV / Sales | 0.37 |
| EV / EBITDA | 3.44 |
| EV / EBIT | 8.11 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.34 |
| Debt / EBITDA | 3.64 |
| Debt / FCF | n/a |
| Interest Coverage | 5.56 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.02% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 330,437 |
| Profits Per Employee | 14,808 |
| Employee Count | 101,709 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LON:0H4A has paid 234.87 million in taxes.
| Income Tax | 234.87M |
| Effective Tax Rate | 13.30% |
Stock Price Statistics
The stock price has increased by +28.18% in the last 52 weeks. The beta is 1.46, so LON:0H4A's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | +28.18% |
| 50-Day Moving Average | 7.21 |
| 200-Day Moving Average | 6.67 |
| Relative Strength Index (RSI) | 54.44 |
| Average Volume (20 Days) | 899,670 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0H4A had revenue of GBP 33.89 billion and earned 1.52 billion in profits. Earnings per share was 1.26.
| Revenue | 33.89B |
| Gross Profit | 5.00B |
| Operating Income | 1.65B |
| Pretax Income | 1.77B |
| Net Income | 1.52B |
| EBITDA | 3.32B |
| EBIT | 1.65B |
| Earnings Per Share (EPS) | 1.26 |
Balance Sheet
The company has 7.58 billion in cash and 12.09 billion in debt, giving a net cash position of -4.51 billion.
| Cash & Cash Equivalents | 7.58B |
| Total Debt | 12.09B |
| Net Cash | -4.51B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 9.03B |
| Book Value Per Share | 7.50 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 14.76%, with operating and profit margins of 4.88% and 4.48%.
| Gross Margin | 14.76% |
| Operating Margin | 4.88% |
| Pretax Margin | 5.21% |
| Profit Margin | 4.48% |
| EBITDA Margin | 9.79% |
| EBIT Margin | 4.88% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.26, which amounts to a dividend yield of 3.38%.
| Dividend Per Share | 0.26 |
| Dividend Yield | 3.38% |
| Dividend Growth (YoY) | -1.10% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | 3.32% |
| Earnings Yield | 19.92% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |